Compare NSPR & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | RGS |
|---|---|---|
| Founded | 2005 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1M | 72.0M |
| IPO Year | 2009 | 1994 |
| Metric | NSPR | RGS |
|---|---|---|
| Price | $0.72 | $27.93 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 157.0K | 3.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.24 |
| EPS | N/A | ★ 0.89 |
| Revenue | $2,310,000.00 | ★ $210,134,000.00 |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $30.81 |
| Revenue Growth | N/A | ★ 3.52 |
| 52 Week Low | $0.69 | $18.23 |
| 52 Week High | $2.93 | $31.50 |
| Indicator | NSPR | RGS |
|---|---|---|
| Relative Strength Index (RSI) | 28.77 | 49.65 |
| Support Level | N/A | $26.06 |
| Resistance Level | $1.04 | $28.51 |
| Average True Range (ATR) | 0.09 | 0.83 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 5.72 | 56.91 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.